Bio-Techne (TECH) Non-Current Assets (2009 - 2026)

Bio-Techne (TECH) recorded quarterly Non-Current Assets of $1.9 billion in Q1 2026, down 1.2% quarter-over-quarter from $1.9 billion in Q4 2025, and down 7.66% on a YoY basis from $2.0 billion in Q1 2025.

Bio-Techne (TECH) Non-Current Assets (2009 - 2026) Analysis & Trends

Bio-Techne's Non-Current Assets history runs 18 years deep, the most recent figure standing at $1.9 billion for Q1 2026.

  • In Q1 2026, Non-Current Assets fell 7.66% year-over-year to $1.9 billion; the TTM figure through Mar 2026 stood at $7.7 billion (down 6.9% YoY), while the FY2025 annual figure was $245.7 million, down 2.16% from the prior year.
  • Non-Current Assets was $1.9 billion for Q1 2026 at Bio-Techne, down from $1.9 billion in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $2.2 billion in Q3 2023 to a low of $223.2 million in Q2 2022.
  • Historically, Non-Current Assets has averaged $1.6 billion across 5 years, with a median of $1.9 billion in 2025.
  • The sharpest annual moves came in 2023 and 2025: Non-Current Assets climbed 20.3% in 2023, then decreased 8.18% in 2025.
  • A 5-year view of Non-Current Assets shows it stood at $1.8 billion in 2022, then rose by 19.01% to $2.1 billion in 2023, then slipped by 4.87% to $2.0 billion in 2024, then dropped by 7.39% to $1.9 billion in 2025, then slipped by 1.2% to $1.9 billion in 2026.
  • The last three Non-Current Assets figures came in at $1.9 billion (Q1 2026), $1.9 billion (Q4 2025), and $1.9 billion (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 62,953.78
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 289.41 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 4.56 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 486.60 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 30.30 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 5.18 Mn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 14.75 Bn
9 Abivax 91.96 Bn 91.96 Bn - 39.71 Mn
10 Bio-Techne 9.04 Bn 8.83 Bn 208.29 Mn 1.86 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.86 Bn
Dec 31, 2025 1.89 Bn
Sep 30, 2025 1.92 Bn
Jun 30, 2025 245.72 Mn
Mar 31, 2025 2.02 Bn
Dec 31, 2024 2.04 Bn
Sep 30, 2024 2.09 Bn
Jun 30, 2024 251.15 Mn
Mar 31, 2024 2.11 Bn
Dec 31, 2023 2.14 Bn
Sep 30, 2023 2.16 Bn
Jun 30, 2023 226.20 Mn
Mar 31, 2023 2.03 Bn
Dec 31, 2022 1.80 Bn
Sep 30, 2022 1.80 Bn
Jun 30, 2022 223.24 Mn
Mar 31, 2022 1.71 Bn
Dec 31, 2021 1.71 Bn
Sep 30, 2021 1.73 Bn
Jun 30, 2021 207.91 Mn